Sözen T, Özışık L, Başaran NÇ (2016) An overview and management of osteoporosis. Eur J Rheumatol 4:46

Article  PubMed  PubMed Central  Google Scholar 

Li J, Qiao J, Li Y, Qin G, Xu Y, Lao K, Wang Y, Fan Y, Tang P, Han L (2025) Metabolic disorders in polycystic ovary syndrome: from gut microbiota biodiversity to clinical intervention (in eng). Front Endocrinol (Lausanne) 16:1526468. https://doi.org/10.3389/fendo.2025.1526468

Article  PubMed  PubMed Central  Google Scholar 

Piovezan JM, Premaor MO, Comim FV (2019) Negative impact of polycystic ovary syndrome on bone health: a systematic review and meta-analysis (in eng). Hum Reprod Update 25:633–645. https://doi.org/10.1093/humupd/dmz020

Article  PubMed  Google Scholar 

Noroozzadeh M, Amiri M, Farhadi-Azar M, Ramezani Tehrani F (2022) Bone Health in Women With Polycystic Ovary Syndrome: A Narrative Review (in eng). J Clin Densitom 25:606–614. https://doi.org/10.1016/j.jocd.2022.02.005

Article  PubMed  Google Scholar 

Mujica LKS, Dos Santos AC, Valente FS, Miyazato LG, Macari S, da Silva TA, Barrioni BR, Carlos BL, Silva GJA, Shimano AC, Antoniazzi AQ, Premaor MO, Comim FV (2023) Bone strength is reduced in a neonatal androgenized rat model (in eng). Bone Rep 19:101710. https://doi.org/10.1016/j.bonr.2023.101710

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mujica LKS, Glanzner WG, Prante AL, Rissi VB, Correa GRE, Premaor MO, Antoniazzi AQ, Gonçalves PBD, Comim FV (2021) Trabecular bone is increased in a rat model of polycystic ovary syndrome (in eng). Exp Clin Endocrinol Diabetes 129:757–761. https://doi.org/10.1055/a-1284-5491

Article  PubMed  CAS  Google Scholar 

Sudhakaran G, Priya PS, Jagan K, Haridevamuthu B, Meenatchi R, Arockiaraj J (2023) Osteoporosis in polycystic ovary syndrome (PCOS) and involved mechanisms (in eng). Life Sci 335:122280. https://doi.org/10.1016/j.lfs.2023.122280

Article  PubMed  CAS  Google Scholar 

Tehrani FR, Noroozzadeh M, Zahediasl S, Piryaei A, Azizi F (2014) Introducing a rat model of prenatal androgen-induced polycystic ovary syndrome in adulthood (in eng). Exp Physiol 99:792–801. https://doi.org/10.1113/expphysiol.2014.078055

Article  PubMed  CAS  Google Scholar 

Noroozzadeh M, Ramezani Tehrani F, Sedaghat K, Godini A, Azizi F (2015) The impact of prenatal exposure to a single dose of testosterone on insulin resistance, glucose tolerance and lipid profile of female rat’s offspring in adulthood (in eng). J Endocrinol Invest 38:489–495. https://doi.org/10.1007/s40618-014-0198-y

Article  PubMed  CAS  Google Scholar 

Sherman SB, Sarsour N, Salehi M, Schroering A, Mell B, Joe B, Hill JW (2018) Prenatal androgen exposure causes hypertension and gut microbiota dysbiosis. Gut Microb 9:400–21. https://doi.org/10.1080/19490976.2018.1441664

Article  CAS  Google Scholar 

Wu Z, Li W, Jiang K, Lin Z, Qian C, Wu M, Xia Y, Li N, Zhang H, Xiao H, Bai J (2020) Geng D (2024) Regulation of bone homeostasis: signaling pathways and therapeutic targets (in eng). MedComm 5:e657. https://doi.org/10.1002/mco2.657

Article  CAS  Google Scholar 

Yusuf SK, Ahmed H, Solomon KE, Ibraheem GH, Adio AA-I, Samuel OB, Jaji AZ (2025) Epigenetic modifications in bone metabolism: exploring the link with osteoporosis. Human Gene. https://doi.org/10.1016/j.humgen.2025.201449

Article  Google Scholar 

Mills EG, Abbara A, Dhillo WS, Comninos AN (2023) Effects of distinct Polycystic Ovary Syndrome phenotypes on bone health (in eng). Front Endocrinol (Lausanne) 14:1163771. https://doi.org/10.3389/fendo.2023.1163771

Article  PubMed  PubMed Central  Google Scholar 

Yang HY, Lee HS, Huang WT, Chen MJ, Chen SC, Hsu YH (2018) Increased risk of fractures in patients with polycystic ovary syndrome: a nationwide population-based retrospective cohort study. J Bone Miner Metab 36:741–748. https://doi.org/10.1007/s00774-017-0894-8

Article  PubMed  Google Scholar 

Hristova D, Kirilov G (2022) Hormonal status and bone turnover in adolescents with polycystic ovarian syndrome. Clin Exp Obstet Gynecol 49:56

Article  Google Scholar 

Park MH, Kim DH, Lee EK, Kim ND, Im DS, Lee J, Yu BP, Chung HY (2014) Age-related inflammation and insulin resistance: a review of their intricate interdependency (in eng). Arch Pharm Res 37:1507–1514. https://doi.org/10.1007/s12272-014-0474-6

Article  PubMed  PubMed Central  CAS  Google Scholar 

Stamou MI, Colling C, Dichtel LE (2023) Adrenal aging and its effects on the stress response and immunosenescence (in eng). Maturitas 168:13–19. https://doi.org/10.1016/j.maturitas.2022.10.006

Article  PubMed  CAS  Google Scholar 

Mi B, Xiong Y, Knoedler S, Alfertshofer M, Panayi AC, Wang H, Lin S (2024) Ageing-related bone and immunity changes: insights into the complex interplay between the skeleton and the immune system. Bone Res 12:42. https://doi.org/10.1038/s41413-024-00346-4

Article  PubMed  PubMed Central  CAS  Google Scholar 

Falcetta P, Benelli E, Molinaro A, Di Cosmo C, Bagattini B, Del Ghianda S, Salvetti G, Fiore E, Pucci E, Fruzzetti F (2021) Effect of aging on clinical features and metabolic complications of women with polycystic ovary syndrome. J Endocrinol Invest 44:2725–33

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tamura N, Kurabayashi T, Nagata H, Matsushita H, Yahata T, Tanaka K (2005) Effects of testosterone on cancellous bone, marrow adipocytes, and ovarian phenotype in a young female rat model of polycystic ovary syndrome (in eng). Fertil Steril 84:1277–1284. https://doi.org/10.1016/j.fertnstert.2005.06.017

Article  PubMed  CAS  Google Scholar 

Li J, Sarosi I, Cattley RC, Pretorius J, Asuncion F et al (2006) Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia (in eng). Bone 39:754–766. https://doi.org/10.1016/j.bone.2006.03.017

Article  PubMed  CAS  Google Scholar 

Park H, Jo S, Jang MA, Choi SH, Kim TH (2022) Dikkopf-1 promotes matrix mineralization of osteoblasts by regulating Ca(+)-CAMK2A- CREB1 pathway (in eng). BMB Rep 55:627–632. https://doi.org/10.5483/BMBRep.2022.55.12.103

Article  PubMed  PubMed Central  CAS  Google Scholar 

Han Y, Gao H, Gan X, Liu J, Bao C, He C (2023) Roles of IL-11 in the regulation of bone metabolism (in eng). Front Endocrinol (Lausanne) 14:1290130. https://doi.org/10.3389/fendo.2023.1290130

Article  PubMed  Google Scholar 

Shaughnessy SG, Walton KJ, Deschamps P, Butcher M, Beaudin SM (2002) Neutralization of interleukin-11 activity decreases osteoclast formation and increases cancellous bone volume in ovariectomized mice (in eng). Cytokine 20:78–85. https://doi.org/10.1006/cyto.2002.1981

Article  PubMed  CAS  Google Scholar 

De Leon-Oliva D, Barrena-Blázquez S, Jiménez-Álvarez L (2023) The RANK-RANKL-OPG system: a multifaceted regulator of homeostasis, immunity, and cancer. Medicina. https://doi.org/10.3390/medicina59101752

Article  PubMed  PubMed Central  Google Scholar 

Fujiwara Y, Piemontese M, Liu Y, Thostenson JD, Xiong J, O’Brien CA (2016) RANKL (Receptor Activator of NFκB Ligand) produced by osteocytes is required for the increase in B cells and bone loss caused by estrogen deficiency in mice (in eng). J Biol Chem 291:24838–24850. https://doi.org/10.1074/jbc.M116.742452

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ono T, Hayashi M, Sasaki F, Nakashima T (2020) RANKL biology: bone metabolism, the immune system, and beyond (in eng). Inflamm Regen 40:2. https://doi.org/10.1186/s41232-019-0111-3

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yan M, Tsukasaki M, Muro R, Ando Y, Nakamura K, Komatsu N, Nitta T, Okamura T, Okamoto K (2023) Identification of an intronic enhancer regulating RANKL expression in osteocytic cells. Bone Res 11:43. https://doi.org/10.1038/s41413-023-00277-6

Article